Luciano Pacelli

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson et al. · Cancer Immunology Research · 2016 · 407 citations

Immunology, Immunoediting, Immunotherapeutic Drug Discovery +21

Clinical-Grade Mesenchymal Stromal Cells Produced Under Various Good Manufacturing Practice Processes Differ in Their Immunomodulatory Properties: Standardization of Immune Quality Controls

Cédric Menard, Luciano Pacelli, Giulio Bassi et al. · Stem Cells and Development · 2013 · 181 citations · Full text

Cell Therapy, Immune Quality Controls, Lymphocyte Development +27

Comparison of Epithelial Differentiation and Immune Regulatory Properties of Mesenchymal Stromal Cells Derived from Human Lung and Bone Marrow

Mario Ricciardi, Giorgio Malpeli, Francesco Bifari et al. · PLoS ONE · 2012 · 92 citations · Full text

Adult Stem Cell, Immune Regulation, Immunology +18

Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy

Armel Hervé Nwabo Kamdje, G. Bassi, Luciano Pacelli et al. · Blood Cancer Journal · 2012 · 88 citations · Full text

Immunology, Cell Death, Cancer Biology +20

Comparative Study of Immune Regulatory Properties of Stem Cells Derived from Different Tissues

Mariano Di Trapani, Giulio Bassi, Mario Ricciardi et al. · Stem Cells and Development · 2013 · 84 citations · Full text

Cell Therapy, Adult Stem Cell, Immune Regulation +20